BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 23 filers reported holding BAXTER INTL INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $164,763 | -16.0% | 4,367 | +1.5% | 0.00% | 0.0% |
| Q2 2023 | $196,041 | -34.5% | 4,303 | -41.7% | 0.00% | -40.0% |
| Q1 2023 | $299,409 | +2.6% | 7,382 | +28.9% | 0.01% | -16.7% |
| Q4 2022 | $291,952 | -5.8% | 5,728 | -0.6% | 0.01% | 0.0% |
| Q3 2022 | $310,000 | -18.6% | 5,764 | -2.6% | 0.01% | -25.0% |
| Q2 2022 | $381,000 | -19.6% | 5,920 | -3.1% | 0.01% | 0.0% |
| Q1 2022 | $474,000 | -10.7% | 6,112 | -1.1% | 0.01% | -11.1% |
| Q4 2021 | $531,000 | +5.1% | 6,180 | -1.6% | 0.01% | 0.0% |
| Q3 2021 | $505,000 | -7.3% | 6,280 | -7.4% | 0.01% | -10.0% |
| Q2 2021 | $545,000 | +16.7% | 6,780 | +22.6% | 0.01% | +11.1% |
| Q1 2021 | $467,000 | +0.6% | 5,528 | -4.6% | 0.01% | -10.0% |
| Q4 2020 | $464,000 | -1.7% | 5,792 | -1.4% | 0.01% | -9.1% |
| Q3 2020 | $472,000 | -6.5% | 5,873 | 0.0% | 0.01% | -21.4% |
| Q2 2020 | $505,000 | +5.0% | 5,873 | -0.8% | 0.01% | -12.5% |
| Q1 2020 | $481,000 | +1.3% | 5,921 | +4.2% | 0.02% | +33.3% |
| Q4 2019 | $475,000 | -8.5% | 5,685 | -4.2% | 0.01% | -20.0% |
| Q3 2019 | $519,000 | +7.2% | 5,935 | +0.4% | 0.02% | +7.1% |
| Q2 2019 | $484,000 | +0.6% | 5,912 | 0.0% | 0.01% | -6.7% |
| Q1 2019 | $481,000 | +17.0% | 5,912 | -5.4% | 0.02% | +7.1% |
| Q4 2018 | $411,000 | -9.7% | 6,251 | +5.7% | 0.01% | 0.0% |
| Q3 2018 | $455,000 | +4.4% | 5,912 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $436,000 | +13.5% | 5,912 | 0.0% | 0.01% | +7.7% |
| Q1 2018 | $384,000 | +8.8% | 5,912 | +8.2% | 0.01% | +8.3% |
| Q4 2017 | $353,000 | +2.9% | 5,462 | 0.0% | 0.01% | -7.7% |
| Q3 2017 | $343,000 | +12.5% | 5,462 | +8.2% | 0.01% | +8.3% |
| Q2 2017 | $305,000 | +16.4% | 5,046 | 0.0% | 0.01% | +9.1% |
| Q1 2017 | $262,000 | +24.2% | 5,046 | +6.3% | 0.01% | +22.2% |
| Q4 2016 | $211,000 | -6.6% | 4,746 | 0.0% | 0.01% | -10.0% |
| Q3 2016 | $226,000 | +5.6% | 4,746 | 0.0% | 0.01% | +11.1% |
| Q2 2016 | $214,000 | +7.0% | 4,746 | -2.4% | 0.01% | 0.0% |
| Q1 2016 | $200,000 | -20.0% | 4,863 | -25.9% | 0.01% | -18.2% |
| Q4 2015 | $250,000 | +20.8% | 6,563 | +4.0% | 0.01% | +10.0% |
| Q3 2015 | $207,000 | -53.1% | 6,312 | 0.0% | 0.01% | -50.0% |
| Q2 2015 | $441,000 | -11.1% | 6,312 | -12.9% | 0.02% | -13.0% |
| Q1 2015 | $496,000 | -2.6% | 7,250 | +4.4% | 0.02% | -4.2% |
| Q4 2014 | $509,000 | +2.2% | 6,945 | 0.0% | 0.02% | 0.0% |
| Q3 2014 | $498,000 | -1.0% | 6,945 | -0.0% | 0.02% | -4.0% |
| Q2 2014 | $503,000 | -2.5% | 6,948 | -1.0% | 0.02% | -3.8% |
| Q1 2014 | $516,000 | +4.5% | 7,020 | -1.3% | 0.03% | +4.0% |
| Q4 2013 | $494,000 | +5.1% | 7,114 | -0.5% | 0.02% | 0.0% |
| Q3 2013 | $470,000 | -10.0% | 7,152 | -5.1% | 0.02% | -13.8% |
| Q2 2013 | $522,000 | – | 7,539 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |